Poster presented at the American Public Health Association (APHA) and American College of Neuropsychopharmacology (ACNP), 2005.
Lawrence S. Brown Jr., MD, MPH (Addiction Research and Treatment Corporation, NY Node), Steven Allan Kritz, MD (Addiction Research and Treatment Corporation, NY Node), John Rotrosen, MD (VA New York Harbor Healthcare System, NYU School of Medicine, NY Node), R. Jeffrey Goldsmith, MD (Cincinnati VA Medical Center, OV Node), Edmund J. Bini, MD, MPH (VA New York Harbor Healthcare System, NYU School of Medicine, NY Node), James A. Robinson, MEd (Nathan Kline Institute), Sherryl Baker, PhD.
In the US, users of illicit drugs will largely sustain the epidemics of HIV/AIDS, hepatitis C, and sexually transmitted infections. Substance abuse treatment programs can play a major role in stemming these epidemics. A nationwide CTN study, protocol CTN-0012, examines these three infection groups from the perspective of administrators and clinicians working in substance abuse treatment programs. Three surveys were developed; one each for substance abuse treatment program administrators and clinicians, and one for state health and substance abuse department administrators. The surveys looked at service availability, government mandates, funding, and other key elements involved in evaluating and caring for patients in each of the three infection groups. Preliminary data is presented in this poster. This study will allow for examination of associations between the activities at substance abuse treatment programs and the policies of the states within which they are located in dealing with the three infection groups. This data and other information can then be used to encourage “best practices” in treating these epidemic infections. (Poster, PowerPoint slides, English, 2006)
Keywords: Community health services | Health services research | Hepatitis C | HIV/AIDS | Research design | Sexually transmitted diseases | American Public Health Association (APHA) annual meeting, 2005 | American College of Neuropsychopharmacology (ACNP) annual meeting, 2005
Document No: 130
Submitted by Lawrence S. Brown Jr., MD, MPH, FASAM, Lead Investigator (6/19/2005).